__timestamp | BioCryst Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 13486000 | 116287000 |
Thursday, January 1, 2015 | 46361000 | 136004000 |
Friday, January 1, 2016 | 23654000 | 203017000 |
Sunday, January 1, 2017 | 23484000 | 287023000 |
Monday, January 1, 2018 | 20182000 | 393541000 |
Tuesday, January 1, 2019 | 44734000 | 376095000 |
Wednesday, January 1, 2020 | 16136000 | 467938000 |
Friday, January 1, 2021 | 149906000 | 504714000 |
Saturday, January 1, 2022 | 264233000 | 580017000 |
Sunday, January 1, 2023 | 326751000 | 523742000 |
Cracking the code
In the competitive world of pharmaceuticals, financial performance is a key indicator of a company's success. This analysis compares the gross profits of Supernus Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. over the past decade, from 2014 to 2023. Supernus Pharmaceuticals consistently outperformed BioCryst Pharmaceuticals, with an average gross profit nearly four times higher. In 2022, Supernus reached its peak with a gross profit of approximately $580 million, while BioCryst's highest was around $327 million in 2023. This trend highlights Supernus's robust market strategy and operational efficiency. Despite BioCryst's significant growth, particularly from 2021 onwards, it still trails behind Supernus. This financial snapshot provides valuable insights into the strategic positioning and market dynamics of these two industry players, offering a glimpse into their future potential.
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Biogen Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Key Insights on Gross Profit: Catalent, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs BioCryst Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: BioCryst Pharmaceuticals, Inc. and Evotec SE Trends